Vanderbilt Vaccine Center

Shown here is the research team that discovered monoclonal antibodies that protect against COVID-19 in high-risk individuals.
August 24, 2022

COVID antibody research conducted at VUMC lands national award

A long-acting antibody combination discovered at Vanderbilt University Medical Center that protects against COVID-19 in high-risk individuals has received a gold medal in the 2022 R&D 100 awards program announced Aug. 22 by R&D World Magazine.

By Bill Snyder
July 14, 2022

Darling honored by Society of Research Administrators

Vanderbilt’s Heather Darling, PMP, has been selected as a Future of the Field honoree by the Society of Research Administrators International.

By Bill Snyder
July 1, 2022

VUMC in the news, July 5, 2022

June 8, 2022

Research probes cause of acute flaccid myelitis in children

Research that began at Vanderbilt University Medical Center has found evidence that a viral infection followed by a “robust” immune response is the cause of a polio-like paralyzing illness in children called acute flaccid myelitis (AFM).

By Bill Snyder
March 31, 2022

Crowe receives national award for COVID antibody research

Vanderbilt’s James Crowe Jr., MD, and Michel Nussenzweig, MD, PhD, of The Rockefeller University, have been jointly awarded the 2022 Harrington Prize for Innovation in Medicine for “groundbreaking work” that enabled the use of human antibodies to treat COVID-19.

By Bill Snyder
Lawrence Marnett, PhD, left, and Jennifer Pietenpol, PhD, right, presented 2021 Research Staff Awards to Kimberly Newsom, second from left, Tracie Baker, CCRP, and Pavlo Gilchuk, PhD.
March 9, 2022

Research Staff Awards honor those who help drive science forward

Laboratory and administrative personnel at Vanderbilt University Medical Center were honored March 4 for research excellence during the 18th annual Research Staff Awards Ceremony.

By Bill Snyder
February 17, 2022

Pandemic leads to broader use of monoclonal antibodies

Antiviral drugs and coronavirus-fighting monoclonal antibodies, including those discovered at Vanderbilt University Medical Center, remain crucially important in the continuing fight against COVID-19.
By Bill Snyder
January 20, 2022

Omicron evades some but not all monoclonal antibodies: study

A new study found that several, but not all, of the human monoclonal antibodies used clinically to prevent patients from becoming severely ill from COVID-19 may not be protective against the Omicron variant now sweeping across the United States.
By Bill Snyder
December 23, 2021

Patient receives antibodies discovered at Vanderbilt to prevent COVID-19 illness

On Dec. 22, Caroline Davis of Nashville became the first patient at Vanderbilt University Medical Center to receive injections of a new antibody combination to protect her from COVID-19.
By Bill Snyder
December 9, 2021

Antibodies discovered at Vanderbilt for prevention of COVID-19 granted FDA emergency use authorization

The U.S. Food and Drug Administration granted emergency use authorization (EUA) to the global biopharmaceutical company AstraZeneca for a long-acting antibody combination which  protects against COVID-19, discovered last year at Vanderbilt University Medical Center.
By Bill Snyder
December 2, 2021

Long-acting antibody combo developed at VUMC reduces COVID-19 risk and symptoms

By Bill Snyder
November 19, 2021

VUMC sources quoted by New York Times, Washington Post, CNN, more

November 18, 2021

Seven from VUMC among most highly cited researchers

Seven Vanderbilt faculty members have made this year’s list of scientists whose papers have been cited most frequently by other researchers.
By Bill Snyder
1 2 3 4 5 … 14